Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
NCT ID: NCT03871894
Last Updated: 2022-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
83 participants
INTERVENTIONAL
2019-03-12
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Part II- Randomized Controlled Study All the eligible, critically ill cirrhotic patients on mechanical ventilator support would be randomized to a control group (receiving the nutritional therapy as per the standard enteral nutritional practice in a critical care setting) or the intervention group (receiving enteral nutrition based on proposed measured requirements by Indirect calorimetry (IC) given till the patient is in ICU(Intensive care unit). The IC would be done thrice a week in both groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients
NCT02017301
Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease
NCT02140294
Methods for Nutritional Assessment in Cirrhosis
NCT02926261
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
NCT02528760
To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics
NCT06462872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm
This is the group of critically ill cirrhotic patients on mechanical ventilator support who would receive the nutritional therapy as per the standard enteral nutritional practice in a critical care setting in cirrhotics till the period admitted in ICU(Intensive care unit) 35-40 Kcal/Kg IBW/day; 1.5g protein per kg per day.
Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit)
Nutrition therapy based on measured energy expenditure by indirect calorimetry (IC) done alternate day till patient on ventilatory support and protein intake 1.5 g/kg IBW/day
Standard and fixed nutritional intervention till patient in ICU
Fixed standard nutritional therapy 35-40 Kcal/Kg IBW/day and 1.5 g protein /Kg IBW/Day till patient on ventilator
Intervention arm
This is the group of critically ill cirrhotic patients on mechanical ventilator support who would receive the nutritional therapy based on indirect calorimetry measurements till the period admitted in ICU(Intensive care unit); 1.5g protein per kg per day.
Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit)
Nutrition therapy based on measured energy expenditure by indirect calorimetry (IC) done alternate day till patient on ventilatory support and protein intake 1.5 g/kg IBW/day
Standard and fixed nutritional intervention till patient in ICU
Fixed standard nutritional therapy 35-40 Kcal/Kg IBW/day and 1.5 g protein /Kg IBW/Day till patient on ventilator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit)
Nutrition therapy based on measured energy expenditure by indirect calorimetry (IC) done alternate day till patient on ventilatory support and protein intake 1.5 g/kg IBW/day
Standard and fixed nutritional intervention till patient in ICU
Fixed standard nutritional therapy 35-40 Kcal/Kg IBW/day and 1.5 g protein /Kg IBW/Day till patient on ventilator
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
• Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit and those admitted in ward.
Disease controls:
* Patients with Acute liver failure (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
* Patients with severe acute pancreatitis (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
Healthy Controls:
* Healthy subjects- Relatives of patients with no known chronic diseases (Chronic obstructive pulmonary disease, Coronary artery disease, Type 2 diabetes, Hypertension, Hypothyroidism, Koch's disease) or not on any long term medications.
* Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit who require mechanical ventilation
Exclusion Criteria
* Active upper gastrointestinal bleeding
* If there are conditions which precluded IC, such as an FiO2 \>60 %, failure to cooperate, agitation, seizure activity, spasticity, or positive end-expiratory pressure (PEEP) \>10 mmHg.
* Pregnant women
* Refused to consent/ inability to obtain informed consent.
* Known long standing diabetic
* If there is any evidence of medical/surgical instability
* Hepatocellular carcinoma Extrahepatic malignancies
* With persistent gastrointestinal dysfunction and ileus
* Patients who would be readmitted to the ICU
* Known long standing diabetic
* Terminally ill patients on high inotropic support
* Acute liver failure
* If there is any evidence of medical/surgical instability
* If patients are taking any portion of nutrition by mouth.
* Pregnant women
* Refused to consent/ inability to obtain informed consent.
* Patient on CRRT- continuous renal replacement therapy
* Severe co morbidities such as Chronic kidney disease requiring maintenance dialysis, COPD and Cardiac pathologies (Acute myocardial infarction, heart failure, ).
* Hepatocellular carcinoma Extrahepatic malignancies
* Moribund patient with likely survival \<24 hours
* Patients enrolled in other drug trials.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Liver and Biliary Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaya Benjamin, Msc,PhD
Role: STUDY_DIRECTOR
Institute of Liver and Biliary Sciences, sector D-1, Vasantkunj, New Delhi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ILBS
New Delhi, National Capital Territory of Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILBS-METALIC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.